Loading…
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $229M | $15M | $10M | $11M | 28.3% | 14.2% | 233.8% |
| 2024 | $200M | $8M | $3M | $10M | 11.3% | -6.2% | 15.6% |
| 2023 | $213M | $8M | $3M | $4M | 7.3% | 3.4% | -18.6% |
| 2022 | $206M | $8M | $3M | $6M | 9.9% | - | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total Revenue | 206.36 | 213.40 | 200.16 | 228.53 |
| Cost Of Revenue | 38.10 | 43.39 | 41.44 | 44.86 |
| Gross Profit | 168.26 | 170.01 | 158.72 | 183.67 |
| Operating Expense | 160.69 | 165.75 | 154.39 | 171.47 |
| Operating Income | 7.58 | 4.26 | 4.33 | 12.20 |
| EBITDA | 7.96 | 7.84 | 7.91 | 15.36 |
| EBIT | 4.70 | 4.26 | 4.33 | 12.20 |
| Pretax Income | 4.69 | 4 | 4.35 | 12.24 |
| Tax Provision | 1.57 | 1.46 | 1.41 | 2.44 |
| Net Income | 3.12 | 2.54 | 2.94 | 9.80 |
| Net Income Common Stockholders | 3.12 | 2.54 | 2.94 | 9.80 |
| Total Expenses | 198.78 | 209.14 | 195.83 | 216.33 |
| Interest Expense | 0.01 | 0 | 0 | 0 |
| Interest Income | 0 | 0.20 | 0.43 | 0.43 |
| Selling General And Administration | 63.42 | 71.06 | 68.47 | 69.21 |
| Normalized EBITDA | 10.88 | 8.21 | 8.34 | 15.73 |
| Normalized Income | 5.06 | 2.78 | 3.23 | 10.11 |
| Basic EPS | 0.24 | 0.20 | 0.24 | 0 |
| Diluted EPS | 0.24 | 0.20 | 0.23 | 0 |
| Tax Effect Of Unusual Items | -0.98 | -0.14 | -0.14 | -0.08 |
| Tax Rate For Calcs | 0.34 | 0.36 | 0.32 | 0.20 |
| Total Unusual Items | -2.92 | -0.37 | -0.43 | -0.38 |
| Total Unusual Items Excluding Goodwill | -2.92 | -0.37 | -0.43 | -0.38 |
| Net Income From Continuing Operation Net Minority Interest | 3.12 | 2.54 | 2.94 | 9.80 |
| Reconciled Depreciation | 3.26 | 3.58 | 3.58 | 3.16 |
| Reconciled Cost Of Revenue | 38.10 | 43.39 | 41.44 | 44.86 |
| Net Interest Income | -0.01 | 0.20 | 0.43 | 0.43 |
| Net Income From Continuing And Discontinued Operation | 3.12 | 2.54 | 2.94 | 9.80 |
| Total Operating Income As Reported | 7.58 | 4.26 | 4.33 | 12.20 |
| Diluted Average Shares | 13.07 | 12.57 | 12.99 | 0 |
| Basic Average Shares | 12.89 | 12.56 | 12.46 | 0 |
| Diluted NI Availto Com Stockholders | 3.12 | 2.54 | 2.94 | 9.80 |
| Net Income Including Noncontrolling Interests | 3.12 | 2.54 | 2.94 | 9.80 |
| Net Income Continuous Operations | 3.12 | 2.54 | 2.94 | 9.80 |
| Other Income Expense | -2.87 | -0.46 | -0.41 | -0.39 |
| Other Non Operating Income Expenses | 0.04 | -0.09 | 0.02 | -0.01 |
| Special Income Charges | -2.21 | 0 | 0 | 0 |
| Gain On Sale Of Ppe | 0 | 0 | 0 | 0 |
| Write Off | 2.21 | 0 | 0 | 0 |
| Gain On Sale Of Security | -0.71 | -0.37 | -0.43 | -0.38 |
| Net Non Operating Interest Income Expense | -0.01 | 0.20 | 0.43 | 0.43 |
| Interest Expense Non Operating | 0.01 | 0 | 0 | 0 |
| Interest Income Non Operating | 0 | 0.20 | 0.43 | 0.43 |
| Other Operating Expenses | 97.26 | 94.69 | 85.92 | 102.26 |
| Selling And Marketing Expense | 97.26 | 94.69 | 85.92 | 0 |
| General And Administrative Expense | 63.42 | 71.06 | 68.47 | 69.21 |
| Other Gand A | 63.42 | 71.06 | 68.47 | 69.21 |
| Operating Revenue | 158.49 | 169.21 | 176.06 | 200.26 |
Consumer Defensive sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| LifeVantage Corporationthis co. | LFVN | $65M | 8.42↓ discount | 1.96 | 28.3% | 5.53 |
| HF Foods Group Inc. | HFFG | $103M | - | 0.51 | -19.1% | 9.29 |
| Waldencast plc | WALD | $98M | - | 0.20 | -45.9% | -42.73 |
| Solesence, Inc. | SLSN | $92M | 65.00 | 5.20 | 10.2% | 46.52 |
| Zevia PBC | ZVIA | $90M | - |
| 1.65 |
| -27.9% |
| -5.05 |
| FitLife Brands, Inc. | FTLF | $87M | 14.70 | 1.99 | 14.5% | 9.60 |
| Ispire Technology Inc. | ISPR | $76M | - | -9.85 | -6489.3% | -1.88 |
| Skillsoft Corp. | SKIL | $60M | - | -1.97 | 462.6% | 7.01 |
| The Hain Celestial Group, Inc. | HAIN | $58M | - | 0.18 | -111.8% | 8.05 |
| Peer Median | - | 39.85 | 0.35 | -23.5% | 7.53 | |